Additive effects of dihydralazine during enflurane or isoflurane hypotensive anaesthesia for spinal fusion
- 1 May 1988
- journal article
- research article
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 35 (3) , 242-248
- https://doi.org/10.1007/bf03010617
Abstract
Sixteen patients (13–38 yr) undergoing spinal fusion for scoliosis under controlled hypotension were studied to determine the haemodynamic and neuroendocrine responses to TV dihydralazine (1.0 mg · kg-1) followed by 0.5 and 1 MAC of enflurane or isoflurane. Twenty minutes after dihydralazine administration mean arterial pressure (-20 per cent) and systemic vascular resistance (-50 per cent) decreased, and cardiac index (+57 per cent), heart rate (+37 per cent) and intrapulmonary shunt increased. Plasma renin activity and aldosterone and norepinephrine levels increased. Further decreases in mean arterial pressure and in systemic vascular resistance were observed when 0 .5 MAC enflurane or isoflurane were added. With 1 MAC anaesthetic levels a further decrease in mean arterial pressure was observed in both goups, but pressure fell to a lower level with isoflurane than with enflurane (p < 0.01). The reduction of arterial blood pressure to a level of 50–60 mmHg for three to four hours was easy to control and was free of complications. The preliminary PV administration of dihydralazine allowed a reduced volatile agent concentration which attenuated undesirable haemodynamic effects, in spite of renin and norepinephrine release, and permitted a rapid intraoperative awakening. La réponse hémodynamique et neuroendocrinienne à ľinjection intraveineuse de dihydralazine (1.0 mg · kg-1) suivie de ľadministration ďenflurane ou ďisoflurane (0.5 puis 1.0 MAC) a été étudiée chez 16 patients âgés de 13 à 38 ans subissant une correction chirurgicale de scoliose sous hypotension contrôlée. Vingt minutes après ľinjection de dihydralazine, la pression artérielle moyenne et les résistances vasculaires systémiques se sont abaissées (-20 et -50 pour cent respectivement) et ľindex cardiaque et la fréquence cardiaque se sont élevés (+57 et +37 pour cent respectivement) de même que le shunt intrapulmonaire. Une diminution supplémentaire de la pression artérielle moyenne et des résistances vasculaires systémiques a été observée après introduction ďenflurane ou ďisoflurane à MAC 0.5. ľaugmentation de la concentration alvéolaire à MAC 1.0 a majoré la baisse de pression artérielle dans les deux groupes, mais le niveau de pression atteint a été plus bas avec ľisoflurane qu’avec ľenflurane (p < 0.01). La réduction de pression artérielle moyenne à un niveau de 50 à 60 mmHg a été facile à contrôler pendant trois à quatre heures et n’a pas entraîné de complication. ľadministration intraveineuse préalable de dihydralazine permet la réduction des concentrations alvéolaires des agents anesthésiques volatils ce qui atténue leurs effets hémodynamiques indésirables en dépit ďune libération de rénine et de noradrénaline, et donc facilite un réveil peropératoire rapide.This publication has 34 references indexed in Scilit:
- Effect of hydralazine on intrapulmonary shuntCritical Care Medicine, 1986
- Induced hypotensionCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1984
- Contrasting acute effects of vasodilators (nitroglycerin, nitroprusside, and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hypertension: A combined radionuclide-hemodynamic studyThe American Journal of Cardiology, 1983
- Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure.Circulation, 1982
- Respiratory and Cardiovascular Functions in Scoliosis and the Principles of Anesthetic ManagementAnesthesiology, 1980
- Intra‐operative awakening during scoliosis surgeryAnaesthesia, 1980
- Anesthetics and the Renin–Angiotensin–Aldosterone AxisAnesthesiology, 1978
- Hypotensive Anesthesia for Spinal Fusion With Sodium NitroprussideSpine, 1978
- Direct and reflex cardiostimulating effects of hydralazineThe American Journal of Cardiology, 1977
- Vasodilator Therapy of Cardiac FailureNew England Journal of Medicine, 1977